Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Eather

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Respirology Case Reports|September 22, 2018
Management of rifampicin mono-resistant tuberculosis in Queensland, Australia: a retrospective case seriesJustine Gibson, Ellen Donnan, Geoffrey Eather
Australian and New Zealand Journal of Public Health|November 9, 2025
Optimising tuberculosis screening in high-risk groupsTim Aung, Geoffrey Eather, Aleksandra Sasha Jaksic
Respiratory Medicine|October 1, 2020
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case seriesMalcolm Wilson, Bridget O'Connor, Nicholas Matigian, et al.
BMJ Case Reports|December 24, 2018
Pleuropulmonary tuberculosis with spinal lesions due to metastatic malignancy differentiated definitively on imagingJustine Gibson, John Coucher, Chris Coulter, et al.
ERJ Open Research|April 9, 2024
Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markersGeoffrey Eather, Malcolm Wilson, Celine Goffinet, et al.
Emerging Infectious Diseases|October 20, 2017
Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, AustraliaTimothy M Baird, Robyn Carter, Geoffrey Eather, et al.
Respiratory Medicine|November 16, 2019
The clinical significance of Mycobacterium triplexJustine Gibson, Tim Baird, Sushil Pandey, et al.
The European Respiratory Journal|November 30, 2019
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
The European Respiratory Journal|March 19, 2019
<i>M</i> <i>ycobacterium abscessus</i> pulmonary disease: individual patient data meta-analysisNakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
BMJ Open|June 20, 2020
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort studySimone Hj van den Elsen, Marieke Gg Sturkenboom, Onno Akkerman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Respirology Case Reports|September 22, 2018
Management of rifampicin mono-resistant tuberculosis in Queensland, Australia: a retrospective case seriesJustine Gibson, Ellen Donnan, Geoffrey Eather
Australian and New Zealand Journal of Public Health|November 9, 2025
Optimising tuberculosis screening in high-risk groupsTim Aung, Geoffrey Eather, Aleksandra Sasha Jaksic
Respiratory Medicine|October 1, 2020
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case seriesMalcolm Wilson, Bridget O'Connor, Nicholas Matigian, et al.
BMJ Case Reports|December 24, 2018
Pleuropulmonary tuberculosis with spinal lesions due to metastatic malignancy differentiated definitively on imagingJustine Gibson, John Coucher, Chris Coulter, et al.
ERJ Open Research|April 9, 2024
Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markersGeoffrey Eather, Malcolm Wilson, Celine Goffinet, et al.
Emerging Infectious Diseases|October 20, 2017
Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, AustraliaTimothy M Baird, Robyn Carter, Geoffrey Eather, et al.
Respiratory Medicine|November 16, 2019
The clinical significance of Mycobacterium triplexJustine Gibson, Tim Baird, Sushil Pandey, et al.
The European Respiratory Journal|November 30, 2019
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
The European Respiratory Journal|March 19, 2019
<i>M</i> <i>ycobacterium abscessus</i> pulmonary disease: individual patient data meta-analysisNakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, et al.
BMJ Open|June 20, 2020
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort studySimone Hj van den Elsen, Marieke Gg Sturkenboom, Onno Akkerman, et al.
Pageof 1